146 related articles for article (PubMed ID: 8306507)
1. IgG2 subclass restriction of anti-beta 2 glycoprotein 1 antibodies in autoimmune patients.
Arvieux J; Roussel B; Ponard D; Colomb MG
Clin Exp Immunol; 1994 Feb; 95(2):310-5. PubMed ID: 8306507
[TBL] [Abstract][Full Text] [Related]
2. Role of anti-beta 2 glycoprotein 1 antibodies in ESRD patients with antiphospholipid antibody syndrome.
Vaidya S; Daller J; Gugliuzza K
Clin Transplant; 2002 Oct; 16(5):362-7. PubMed ID: 12225433
[TBL] [Abstract][Full Text] [Related]
3. Beta 2-glycoprotein 1 (beta 2GP1) enhances cardiolipin binding activity but is not the antigen for antiphospholipid antibodies.
Pierangeli SS; Harris EN; Davis SA; DeLorenzo G
Br J Haematol; 1992 Nov; 82(3):565-70. PubMed ID: 1486036
[TBL] [Abstract][Full Text] [Related]
4. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P
Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
[TBL] [Abstract][Full Text] [Related]
5. Detection of anti-recombinant beta 2-glycoprotein 1 and anti-recombinant beta 2-glycoprotein 1 fifth-domain antibodies in sera from patients with systemic lupus erythematosus.
Yang CD; Chen SL; Shen N; Qi M; Xu F
Rheumatol Int; 1998; 18(1):5-10. PubMed ID: 9672992
[TBL] [Abstract][Full Text] [Related]
6. Cloning and expression of beta 2-glycoprotein 1 recognized by antiphospholipid antibodies and its clinical investigation.
Chen S; Yang C; Shen N; Xue F
Chin Med J (Engl); 1999 Jan; 112(1):67-71. PubMed ID: 11593645
[TBL] [Abstract][Full Text] [Related]
7. Analytical and clinical relationships between human IgG autoantibodies to beta 2 glycoprotein I and anticardiolipin antibodies.
El-Kadi HS; Keil LB; DeBari VA
J Rheumatol; 1995 Dec; 22(12):2233-7. PubMed ID: 8835554
[TBL] [Abstract][Full Text] [Related]
8. Antiphospholipid Antibodies to Domain I of Beta-2-Glycoprotein I Show Different Subclass Predominance in Comparison to Antibodies to Whole Beta-2-glycoprotein I.
McDonnell T; Artim-Esen B; Wincup C; Ripoll VM; Isenberg D; Giles IP; Rahman A; Pericleous C
Front Immunol; 2018; 9():2244. PubMed ID: 30323817
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus.
Cabral AR; Cabiedes J; Alarcón-Segovia D
Lupus; 2004; 13(3):182-7. PubMed ID: 15119547
[TBL] [Abstract][Full Text] [Related]
10. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when beta 2-glycoprotein I is bound to a suitable surface.
Pengo V; Biasiolo A; Fior MG
Thromb Haemost; 1995 Jan; 73(1):29-34. PubMed ID: 7537919
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity and immunochemical properties of anti-beta2-glycoprotein I autoantibodies.
Arvieux J; Regnault V; Hachulla E; Darnige L; Roussel B; Bensa JC
Thromb Haemost; 1998 Sep; 80(3):393-8. PubMed ID: 9759616
[TBL] [Abstract][Full Text] [Related]
13. Species specificity of anti-beta 2 glycoprotein I autoantibodies and its relevance to anticardiolipin antibody quantitation.
Arvieux J; Darnige L; Hachulla E; Roussel B; Bensa JC; Colomb MG
Thromb Haemost; 1996 May; 75(5):725-30. PubMed ID: 8725713
[TBL] [Abstract][Full Text] [Related]
14. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
Viveros ME; Cabiedes J; Reyes E; Cabral AR
Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
[TBL] [Abstract][Full Text] [Related]
15. Thrombogenic properties of murine anti-cardiolipin antibodies induced by beta 2 glycoprotein 1 and human immunoglobulin G antiphospholipid antibodies.
Pierangeli SS; Liu SW; Anderson G; Barker JH; Harris EN
Circulation; 1996 Oct; 94(7):1746-51. PubMed ID: 8840870
[TBL] [Abstract][Full Text] [Related]
16. Factor VII/VIIa: a new antigen in the anti-phospholipid antibody syndrome.
Bidot CJ; Jy W; Horstman LL; Huisheng H; Jimenez JJ; Yaniz M; Ahn YS
Br J Haematol; 2003 Feb; 120(4):618-26. PubMed ID: 12588348
[TBL] [Abstract][Full Text] [Related]
17. Anticardiolipin and anti-beta 2-GPI are two distinct populations of autoantibodies.
Sorice M; Circella A; Griggi T; Garofalo T; Nicodemo G; Pittoni V; Pontieri GM; Lenti L; Valesini G
Thromb Haemost; 1996 Feb; 75(2):303-8. PubMed ID: 8815581
[TBL] [Abstract][Full Text] [Related]
18. A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies.
Ichikawa K; Tsutsumi A; Atsumi T; Matsuura E; Kobayashi S; Hughes GR; Khamashta MA; Koike T
Arthritis Rheum; 1999 Nov; 42(11):2461-70. PubMed ID: 10555042
[TBL] [Abstract][Full Text] [Related]
19. Anticardiolipin IgG subclasses: association of IgG2 with arterial and/or venous thrombosis.
Sammaritano LR; Ng S; Sobel R; Lo SK; Simantov R; Furie R; Kaell A; Silverstein R; Salmon JE
Arthritis Rheum; 1997 Nov; 40(11):1998-2006. PubMed ID: 9365089
[TBL] [Abstract][Full Text] [Related]
20. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
